We've found
1,587 Leukemia
clinical trials
We've found
1,587 Leukemia
clinical trials
Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 7/24/2014
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
III
Updated: 7/24/2014
Click here to add this to my saved trials

Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/29/2014
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling,
Phase
I
Updated: 1/29/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 1/30/2014
Haplo-identical SCT for HR Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion
Status: Enrolling,
Phase
I, II
Updated: 1/30/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Phase 2 LCL-161 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Validating Pain Scales in Children and Young Adults
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 2/4/2014
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Status: Enrolling,
Phase
II
Updated: 2/4/2014
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Lenalidomide Maintenance With High Risk (HR) Acute Myeloid Leukemia (AML) in Remission
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 4/18/2018
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
Status: Enrolling,
Phase
II
Updated: 4/18/2018
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 4/18/2018
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
Status: Enrolling,
Phase
II
Updated: 4/18/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Hyper-CVAD Regimen in Sequential Combination With Blinatumomab as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 9/5/2017
Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed or Refractory Solid Tumors and Leukemias
Status: Enrolling,
Phase
I
Updated: 9/5/2017
Click here to add this to my saved trials

Leukemia Clinical Trial
Updated: 12/31/1969
A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 2/24/2010
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Status: Enrolling
Updated: 2/24/2010
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 5/3/2011
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Click here to add this to my saved trials
